General Information of Drug (ID: DM0YZC6)

Drug Name
Fulvestrant Drug Info
Synonyms
Faslodex; AstraZeneca brand of fulvestrant; Fulvestrant [USAN]; Ici 182780; ZD 182780; ZM 182780; Faslodex (TN); ZD-182780; ZD-9238; ZM-182780; Faslodex(ICI 182,780); Faslodex, ICI 182780, Fulvestrant; Fulvestrant (JAN/USAN/INN); (7R,13S,17S)-13-methyl-7-(9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol; (7R,8R,9S,13S,14S,17S)-13-methyl-7-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl]-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol; (7R,8S,9S,13S,14S,17S)-13-methyl-7-[9-(4,4,5,5,5-pentafluoropentylsulfinyl) nonyl]-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol; (7alpha,17beta)-7-{9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl}estra-1,3,5(10)-triene-3,17-diol; 7-(9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl)estra-1,3,5(10)-triene-3,17-diol; 7alpha-(9-((4,4,5,5,5,-Pentafluoropentyl)sulfinyl)nonyl)estra-1,3,5(10)-triene-3,17beta-diol; 7alpha-(9-((4,4,5,5,5-Pentafluoropentyl)sulfinyl)nonyl)estra-1,3,5(10)-triene-3,17beta-diol; 7alpha-[9[(4,4,5,5,5-Pentafluropentyl)sulfinyl]nonyl]-estra-1,3,5(10)-triene-3, 17 beta diol; ICI
Therapeutic Class
Anticancer Agents
Cross-matching ID
PubChem CID
104741
ChEBI ID
CHEMBL1358
CAS Number
CAS 129453-61-8
TTD ID
D0JO7Y
INTEDE Drug ID
DR0756

Molecule-level Activity Landscape of This Drug

Molecule Name Gene Name UniProt ID Type IC50 (nM) Details
Loading IC50 data...
Molecule Name Gene Name UniProt ID Type EC50 (nM) Details
Loading EC50 data...
Molecule Name Gene Name UniProt ID Type Kd (nM) Details
Loading Kd data...
Molecule Name Gene Name UniProt ID Type Ki (nM) Details
Loading Ki data...

Experimental Drug Sensitivity Data Across Cancer Cell Lines

Cell Line Related Disease IC50 (Log₂ µM) Original Dataset Details
Loading Cell Activity data...

Cytotoxic Activity Landscape of This Drug

Loading...
Cell Line Disease Value (nM) ChEMBL Assay ID Details
Loading ChEMBL activity data...